ESTEE LAUDER COMPANIES-CL A (EL)       280.86  +0.06 (+0.02%)

280.86  +0.06 (+0.02%)

US5184391044 - Common Stock


Fundamental Rating

4

Overall EL gets a fundamental rating of 4 out of 10. We evaluated EL against 38 industry peers in the Personal Products industry. EL has a great profitability rating, but there are some minor concerns on its financial health. EL is valued expensive and it does not seem to be growing.




Profitability

Profitability Rating

7

EL has a Return On Assets of 10.94%. This is better than the industry average of 4.96%.
EL's Return On Equity of 39.64% is amongst the best returns of the industry. EL outperforms 93% of its industry peers. The industry average return on equity is 9.02%.

EL has a Profit Margin of 12.66%. This is amongst the best returns in the industry. The industry average is 6.73%. EL outperforms 88% of its industry peers.
EL has a Piotroski-F score of 5.00. This indicates an average health and profitability for EL.
VS Industry

ROA (10.94%) VS Industry: 72% outperformed.

0.42
46.29

ROE (39.64%) VS Industry: 93% outperformed.

0.69
100.37

Profit Margin (12.66%) VS Industry: 88% outperformed.

0.20
37.80

Valuation

Valuation Rating

0

With a Price/Earnings Ratio of 41.92, EL can be considered very expensive at the moment.
EL's Price/Earning Ratio is slightly more expensive than the industry average, which is at 26.06.
With a Forward Price/Earnings Ratio of 38.46, EL is valued very expensively.
The high PEG Ratio, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.

When comparing the current price to the book value of EL, we can conclude it is valued rather expensively. It is trading at 18.16 times its book value.
When comparing the price book ratio of EL to the average industry price book ratio of 2.22, EL is valued more expensive than its industry peers. 100% of the companies listed in the same industry are valued cheaper.
Compared to an average industry Enterprise Value to EBITDA ratio of 10.85, EL is valued more expensive than its industry peers. 90% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Earnings (41.92) VS Industry: 26% outperformed.

159.33
5.34

Price/Book (18.16) VS Industry: 0% outperformed.

18.16
0.13

Enterprise Value/ EBITDA (25.73) VS Industry: 10% outperformed.

42.70
3.90

Growth

Growth Rating

3

EL shows quite a strong growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 15.72% yearly.
EL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.90%.
EL is expected to show a small growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 9.15% yearly.
EL shows a small growth in Revenue. In the last year, the Revenue has grown by 1.35%.

The Revenue has been growing slightly by 8.45% on average over the past 5 years.
The Revenue is expected to grow by 5.60% on average over the next 5 years.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS15.72% 10.58% -2.9% -24.07% 0.56% 5.87% 9.15%
Revenue8.45% 6.07% 1.35% -5.95% 1.71% 4.19% 5.6%

Health

Health Rating

5

EL has an Altman-Z score of 6.77. This indicates that EL is financially healthy and little risk of bankruptcy at the moment.
The Altman-Z score of EL is much better than the industry average of 1.86. EL has a better rating than 86% of its industry peers.
A Current Ratio of 1.68 indicates that EL should not have too much problems paying its short term obligations.
EL has a Quick Ratio of 1.11. This is a normal value and indicates that EL is financially healthy and should not expect problems in meeting its short term obligations.

The Quick Ratio is in line with the industry averages, which is at 1.23.
The Piotroski-F score of EL is 5.00. This is a neutral score and indicates average health and profitability for EL.
When comparing the Current Ratio of EL to the average industry Current Ratio of 2.53, EL is less able to pay its short term obligations than its industry peers.
Compared to an average industry Debt to Equity Ratio of 0.19, EL is more dependent on financing than its industry peers.
VS Industry

Debt/Equity (0.93) VS Industry: 22% outperformed.

6.58
0.00

Quick Ratio (1.11) VS Industry: 41% outperformed.

0.02
10.34

Current Ratio (1.68) VS Industry: 33% outperformed.

0.16
11.68

Altman-Z (6.77) VS Industry: 86% outperformed.

-194.02
12.71

Dividend

Dividend Rating

4

The dividend of EL is nicely growing with an annual growth rate of 11.74%!
39.46% of the earnings are spent on dividend by EL. This is a low number and sustainable payout ratio.
EL has been paying a dividend for at least 10 years, so it has a reliable track record.
With a yearly dividend of 0.99%, EL is not a good candidate for dividend investing.

Compared to an average industry Dividend Yield of 3.08, EL's dividend is way lower than its industry peers. On top of this 89% of the companies listed in the same industry pay a better dividend than EL!
Compared to an average S&P500 Dividend Yield of 2.41, EL's dividend is way lower than the S&P500 average.
EL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
VS Industry

Dividend Yield (0.99%) VS Industry: 11% outperformed.

0.99
18.78

ESTEE LAUDER COMPANIES-CL A280.86

NYSE:EL (2/2/2023, 8:49:05 AM)+0.06 (+0.02%)

Chartmill FA Rating
GICS Sector Consumer Staples
GICS IndustryGroup Household & Personal Products
GICS Industry Personal Products
Earnings (Last) 11-02 2022-11-02/bmo Earnings (Next) 02-02 2023-02-02
Inst Owners 122.05% Inst Owner Change 0.06%
Ins Owners 0.1% Ins Owner Change 9.23%
Market Cap 100.21B Analysts 80
Price Target 262.06 (-6.69%)

Dividend
Dividend Yield 0.99% Dividend Growth 11.74%
DP 39.46% Ex-Date N/A

Surprises & Revisions
EPS beat(2) 2 Avg EPS beat(2) 13.41%
Min EPS beat(2) 1.66% Max EPS beat(2) 25.16%
EPS beat(4) 4 Avg EPS beat(4) 11.97%
Min EPS beat(4) 1.66% Max EPS beat(4) 25.16%
Revenue beat(2) 1 Avg Revenue beat(2) -1.25%
Min Revenue beat(2) -3.01% Max Revenue beat(2) 0.51%
Revenue beat(4) 1 Avg Revenue beat(4) -2.27%
Min Revenue beat(4) -4.46% Max Revenue beat(4) 0.51%
PT rev (1m) 2.28% PT rev (3m) -15.16%
EPS NQ rev (1m) N/A EPS NQ rev (3m) N/A
EPS NY rev (1m) 0% EPS NY rev (3m) -28.6%
Revenue NQ rev (1m) N/A Revenue NQ rev (3m) N/A
Revenue NY rev (1m) 0% Revenue NY rev (3m) -9.57%

Valuation
Industry RankSector Rank
PE 41.92
Fwd PE 38.46
P/S 5.8
P/FCF 67.53
P/OCF 40.56
P/B 18.16
P/tB N/A
EV/EBITDA 25.73
EPS(TTM) 6.7 EY 2.39%
EPS(NY) 7.3 Fwd EY 2.6%
FCF(TTM) 4.16 FCFY 1.48%
OCF(TTM) 6.93 OCFY 2.47%
SpS 48.41 BVpS 15.46
TBVpS -0.25 PEG (NY) N/A
PEG (5Y) 2.67

Profitability
Industry RankSector Rank
ROA 10.94%
ROE 39.64%
ROIC 18.38%
ROICexc 22.96%
ROICexgc 43.8%
OM 18.91%
PM 12.66%
GM 75.28%
ROICexgc(3y) 50.75% ROICexcg growth 3Y -13.44%
ROICexcg growth 5Y 5.99% ROICexc(3y) 23.62%
ROICexc growth 3Y -12.3% ROICexc growth 5Y 3.03%
OM growth 3Y 4.2% OM growth 5Y 4.24%
PM growth 3Y 3.91% PM growth 5Y 4.99%
GM growth 3Y -0.64% GM growth 5Y -0.94%
F-Score 5 Asset Turnover 0.86

Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 3.62
Debt/EBITDA 1.35
Cap/Depr 136.7%
Profit Quality 67.86%
Current Ratio 1.68
Quick Ratio 1.11
Altman-Z 6.77
F-Score 5 WACC 7.89%
ROIC/WACC 5.55 Cap/Depr(3y) 114.29%
Cap/Depr(5y) 118.98% Profit Quality(3y) 143.42%
Profit Quality(5y) 140.81%

Growth
EPS 1Y -2.9% EPS 3Y 10.58%
EPS 5Y 15.72% EPS growth Q2Q -27.51%
EPS Next Y -24.07% EPS Next 2Y 0.56%
EPS Next 3Y 5.87% EPS Next 5Y 9.15%
Revenue growth 1Y 1.35% Revenue growth 3Y 6.07%
Revenue growth 5Y 8.45% Revenue growth Q2Q -10.52%
Revenue Next Year -5.95% Revenue Next 2Y 1.71%
Revenue Next 3Y 4.19% Revenue Next 5Y 5.6%
EBIT growth 1Y 0.8% EBIT growth 3Y 10.52%
EBIT growth 5Y 13.04% EBIT Next Year -1.62%
EBIT Next 3Y 11.58% EBIT Next 5Y 10.6%
FCF growth 1Y -32.36% FCF growth 3Y 4.1%
FCF growth 5Y 9.06% OCF growth 1Y -12%
OCF growth 3Y 6.5% OCF growth 5Y 11.05%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA